Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses

被引：27

作者：

Burgess, Melissa Amber

Bolejack, Vanessa

Van Tine, Brian Andrew

Schuetze, Scott

Hu, James

D'Angelo, Sandra P.

Attia, Steven

Priebat, Dennis A.

Okuno, Scott H.

Riedel, Richard F.

Davis, Lara Emily

Mowa, Sujana

Reed, Damon R.

Butterfield, Lisa Helene

Roszik, Jason

Reinke, Denise K.

Baker, Laurence H.

Maki, Robert G.

Patel, Shreyaskumar

Tawbi, Hussein Abdul-Hassan

机构：

[1] Univ Pittsburgh Phys, Pittsburgh, PA USA

[2] Canc Res & Biostatist, Seattle, WA USA

[3] Washington Univ, St Louis, MO USA

[4] Univ Michigan, Ann Arbor, MI 48109 USA

[5] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[7] Mayo Clin, Jacksonville, FL 32224 USA

[8] Washington Hosp Ctr, Washington, DC 20010 USA

[9] Mayo Clin, Rochester, MN USA

[10] Duke Univ, Med Ctr, Durham, NC USA

[11] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[12] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[13] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[14] Univ Pittsburgh, Canc Inst, Hillman Canc Ctr, Pittsburgh, PA USA

[15] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[16] SARC, Ann Arbor, MI USA

[17] Monter Canc Ctr, Northwell Hlth & Cold Spring Harbor Lab, Lake Success, NY USA

[18] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.11008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

11008

引用

页数：5